Seshadri Neervannan
Chief Operating Officer · 6 filings · Latest: Sep 4, 2026
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | Seshadri Neervannan | Chief Operating Officer | Sep 4, 2026 | Sale | $85.00 | 4,564 | $387.9K | 78,532 | |
TARS | Neervannan Seshadri | — | Sep 4, 2026 | Proposed Sale | $85.00 | 4,564 | $387.9K | — | |
TARS | Seshadri Neervannan | Chief Operating Officer | Mar 20, 2026 | Sale | $66.75 | 2,989 | $199.5K | 82,791 | |
TARS | Neervannan Seshadri | — | Mar 20, 2026 | Proposed Sale | $66.75 | 2,989 | $199.5K | — | |
TARS | Seshadri Neervannan | Chief Operating Officer | Mar 19, 2026 | Sale | $67.00 | 4,589 | $307.5K | 85,780 | |
TARS | Seshadri Neervannan | Chief Operating Officer | Mar 18, 2026 | Sale | $68.71 | 3,610 | $248.0K | 90,369 | |
TARS | Seshadri Neervannan | Chief Operating Officer | Mar 17, 2026 | Sale | $69.42 | 3,125 | $216.9K | 93,979 | |
TARS | Neervannan Seshadri | — | Mar 19, 2026 | Proposed Sale | $67.00 | 4,589 | $307.5K | — | |
TARS | Neervannan Seshadri | — | Mar 18, 2026 | Proposed Sale | $68.71 | 3,610 | $248.0K | — | |
TARS | Seshadri Neervannan | Chief Operating Officer | Mar 15, 2026 | Option Exercise | — | 26,287 | — | 97,104 | |
TARS | Neervannan Seshadri | — | Mar 17, 2026 | Proposed Sale | $69.41 | 3,125 | $216.9K | — | |
TARS | Seshadri Neervannan | Chief Operating Officer | Mar 4, 2026 | Sale | $76.67 | 8,366 | $641.4K | 70,817 | |
TARS | Neervannan Seshadri | — | Mar 4, 2026 | Proposed Sale | $76.67 | 8,366 | $641.4K | — | |
TARS | Neervannan Seshadri | — | Mar 20, 2025 | Proposed Sale | $50.11 | 2,435 | $122.0K | — | |
TARS | Neervannan Seshadri | — | Mar 19, 2025 | Proposed Sale | $47.40 | 2,543 | $120.5K | — | |
TARS | Neervannan Seshadri | — | Mar 18, 2025 | Proposed Sale | $46.28 | 2,605 | $120.6K | — |